Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Senokot-S in Diabetic Gastroparesis
NCT03342157Phase 2Terminated
- Sponsor
- Wake Forest University Health Sciences
- Start
- Apr 2018
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of senna + docusate in diabetic gastroparesis, sponsored by Wake Forest University Health Sciences. Started Apr 2018; status: terminated.
02
Drugs
senna + docusate
03
Conditions
diabetic gastroparesis
Beyond the preview
Go deeper on NCT03342157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03342157.